ChangChun High New Technology Industries (000661) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

ChangChun High New Technology Industries Company Snapshot

Business Description:

ChangChun High New Technology Industries operates in the Medicinals and botanicals sector. Changchun High & New Technology Industries (Group) Inc. is principally engaged in pharmaceutical, real estate and service industries. The Company's pharmaceutical products include genetics engineering medicine and biological medicine. As of December 31, 2010, the Company had four major subsidiaries and one associate, primarily involved in the manufacturing of western and Chinese medicines, the research and development of new medicines, the development of real estate, as well as infrastructure construction, among others. The Company mainly operates its businesses within domestic markets. In our complete report available for purchase the company is compared to: Wuhan Mayinglong Pharmaceutical Group Stock Co.,Ltd, Tianjin Tianyao Pharmaceutical, Ltd. and Jilin Aodong Medicine Industry (Group) Co., Ltd..

ChangChun High New Technology Industries

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 33.60
(Figures in Chinese Renmimbi)

1 Week	n/a	13 Weeks	4.2%

4 Weeks	-17.4%	52 Weeks	-34.9%

ChangChun High New Technology Industries Key Data:

Ticker:	000661	Country:	CHINA

Exchanges:	SZN	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	1,165,962,000 (Year Ending Jan 2011).	Employees:	2,730

Currency:	Chinese Renmimbi	Market Cap:	4,412,572,752

Fiscal Yr Ends:	December	Shares Outstanding:	131,326,570

Share Type:	A Gu	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.